Reports Second-Quarter Diluted EPS of $2.03 on a GAAP Basis, an Increase of 290.4 Percent; Adjusted Diluted EPS of $3.65, an Increase of 22.9 Percent; These Results Include an Unfavorable Impact…
AbbVie Reports Second-Quarter 2026 Financial Results
calendar_today
July 31, 2026
domain
abbvie